Editing Management of Localized and Locally Advanced Disease (section)

==== <span style="color:#ff0000">Indications</span> ====
* '''<span style="color:#ff0000">Alternative approach for management of cT1a solid renal masses <3cm</span>'''
** '''Current technology does not allow for reliable treatment of lesions >4.0 cm, and success rates appear to be highest for tumors <2.5-3.0 cm'''
* '''Relative (4):'''
*# '''Advanced age'''
*# '''Significant comorbidities'''
*# '''Local recurrence after previous nephron-sparing surgery'''
*# '''Hereditary renal cancer who present with multifocal lesions for which multiple PNs might be cumbersome'''
* '''<span style="color:#ff0000">2021 AUA[https://www.auanet.org/guidelines/renal-cancer-renal-mass-and-localized-renal-cancer-guideline]</span>'''
** '''<span style="color:#ff0000">Alternative approach for management of cT1a solid renal masses <3cm</span>'''
*** Patients should be informed about the increased risk of tumor persistence or local recurrence after primary TA, compared to surgical excision, which may be treated with repeat ablation.
***PN seems preferred over TA for cT1a: "PN should be prioritized in the management of patients with clinical T1a renal mass".